InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
6
Disclosed sells
2
T+90 hit rate
25%
T+90 mean return
-15.5%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Walker Paul Edward, Director. Director active across 14 companies, notably Monte Rosa Therapeutics, Inc.. Cumulatively, 17 reports have been published. Breakdown: 6 buys · 2 sells. Total volume traded: €11.5m. History available since 17 November 2021. The latest transaction was disclosed on 10 March 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Walker Paul Edward
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
207,100 shares@ US$11.1167.8% of flowCommon StockSEC:0001193125-26-104714:0
Canonical exit: 8 Jun 2026 (T+90)
1,619,240 sharesCommon StockSEC:0001193125-26-046662:0
189,195 shares@ US$0.01100.0% of flowCommon StockSEC:0001193125-25-232143:0
2,760,860 sharesCommon StockSEC:0000950170-25-072714:0
1,023,103 sharesCommon StockSEC:0000950170-24-107544:0
17,857 shares@ US$56.00100.0% of flowCommon StockSEC:0000950170-24-047683:0
Canonical exit: 21 Jul 2024 (T+90)
333,333 shares@ US$3.00100.0% of flowCommon StockSEC:0001209191-23-042804:0
Canonical exit: 15 Oct 2023 (T+90)
2,000,000 shares0Common StockSEC:0001209191-23-037366:0
4,294,207 sharesCommon StockSEC:0001209191-22-059461:0
597,600 shares@ US$5.02100.0% of flowCommon StockSEC:0001209191-22-051146:0
Canonical exit: 20 Dec 2022 (T+90)
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032331:0
2,631,578 shares@ US$1.90100.0% of flowCommon StockSEC:0001209191-22-024322:0
Canonical exit: 10 Jul 2022 (T+90)
37,570 shares@ US$1.321100.0% of flowCommon StockSEC:0001209191-21-071274:0
5,736,363 shares0Common SharesSEC:0001209191-21-065762:0
1,851,852 sharesCommon StockSEC:0001209191-21-061098:0
Canonical exit: 16 Jan 2022 (T+90)
2,715,968 sharesCommon StockSEC:0001209191-21-044050:0
5,864,718 sharesCommon StockSEC:0001209191-21-044200:0
17 of 17 declarations
About Walker Paul Edward
Walker Paul Edward is an administrator, with 17 filings in total. In the 17 sampled recent filings, the activity is mainly acquisitions, with buys and sells recorded between 2021-06-30 and 2026-03-12, including Trevi Therapeutics, Inc., Allakos Inc., Korro Bio, Inc., Savara Inc and Metacrine, Inc.
